Comprehensive assessment of adverse event profiles associated with bispecific antibodies in multiple myeloma

Abstract Bispecific antibodies (BsAbs) have shown promise in the management of relapsed/refractory multiple myeloma (MM). Despite its efficacy, this class of drugs is associated with significant toxicities. In this study, we conducted a pooled analysis of the available clinical trials on BsAbs for t...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mobina Golmohammadi, Shahzad Raza, Maram Albayyadhi, Hossein Sholehrasa, Jack Khouri, Louis Williams, Doris K. Hansen, Azam Moradi, Xuan Xu, Moath Albliwi, Ali Hajj Ali, Danai Dima, Faiz Anwer, Barry Paul, Majid Jaberi-Douraki
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Publishing Group 2025-08-01
coleção:	Blood Cancer Journal
Acesso em linha:	https://doi.org/10.1038/s41408-025-01334-5
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!